コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ylsulfatase B (ARSB; N-acetylgalactosamine-4-sulfatase).
2 he steroid hormone-modulating enzyme steroid sulfatase.
3 e, consistent with inhibition of iduronate 2-sulfatase.
4 sulfate and heparin can inhibit iduronate 2-sulfatase.
5 ed de-sulfation, owing to the induction of a sulfatase.
6 ive form and identify it as a specific HSGAG sulfatase.
7 c cysteinyl or seryl residue on the relevant sulfatase.
8 structure-function investigation of the 2-O-sulfatase.
9 g activities of QSulf1, a novel cell surface sulfatase.
10 ase, aryl sulfatase, and galactose-6-sulfate sulfatase.
11 unction, beta-glucocerebrosidase and steroid sulfatase.
12 and one homologous to N-acetylglucosamine-6-sulfatase.
13 one sulfate to estrone by the enzyme estrone sulfatase.
14 ross-feeding mediated by Bacteroides-encoded sulfatases.
15 smaller than those generated by S-O cleaving sulfatases.
16 ytic metalloenzymes such as phosphatases and sulfatases.
17 ted to heparan-specific N-acetyl glucosamine sulfatases.
18 sidue that is also conserved in carbohydrate sulfatases.
19 and remyelination by blocking OPC-expressed sulfatases.
20 ranch that contains all known AP superfamily sulfatases.
21 the polysaccharide utilisation loci encoded sulfatases.
22 emical characterization of four GAG-specific sulfatases.
23 ncy, as shown before for all other lysosomal sulfatases.
24 based on genetically conserved mycobacterial sulfatases.
25 on of the catalytic formylglycine residue in sulfatases.
26 es have proposed a tumor suppressor role for sulfatase 1 (SULF1) in hepatocellular carcinoma (HCC); h
28 wn that the heparin-degrading endosulfatase, sulfatase 1 (SULF1), functions as a liver tumor suppress
31 atent TGF-beta-binding protein 2) and Sulf1 (sulfatase 1), which are translationally regulated by EPR
33 network-based transcriptomics, we identified sulfatase 2 (Sulf2) mRNA in activated human primary OPCs
35 ), pleckstrin domain-containing A3 (PHLDA3), sulfatase 2 (SULF2), B cell translocation gene 2 (BTG2),
36 ssor, but the role of the related sulfatase, sulfatase 2 (SULF2), in liver carcinogenesis remains to
37 aining beta-glucuronidase (100 U mL(-1)) and sulfatase (2.5 U mL(-1)) for 5 min (37 degrees C; pH 6)
38 lls) are 5, (IC50(aromatase) = 0.82 nM; IC50(sulfatase) = 39 nM), and 14, (IC50(aromatase) = 0.77 nM;
40 orted specificities for the F. heparinum 2-O-sulfatase, 6-O-sulfatase, and unsaturated glucuronyl hyd
41 tations in the IDS gene encoding iduronate-2-sulfatase, a crucial enzyme in the lysosomal degradation
42 a catalytic formylglycine residue of steroid sulfatases, a residue that is also conserved in carbohyd
47 The spectrum of glycosidase and glycoside sulfatase activities in the synovial fluid from patients
48 addition of camalexin complemented both the sulfatase activity and the loss of plant growth promotio
49 The inhibition of MDA-MB-231 cell estrone sulfatase activity by this compound was found to be irre
51 N-alkanoyl tyramines to inhibit: (a) estrone sulfatase activity in intact cultures of human breast ca
55 dent microbiota-specific phenotypes: A lower sulfatase activity in the rhizosphere and a loss of plan
57 normal barrier homeostasis, neither steroid sulfatase activity nor mRNA levels are upregulated follo
58 t compounds (1 microM) inhibited the estrone sulfatase activity of intact MDA-MB-231 cells; however,
59 an metabolic pathways; understanding of endo sulfatase activity questioning the paradigm of how the '
60 the mutant, a significant amount of residual sulfatase activity suggests the presence of FGE-independ
61 SUMF1 demonstrated that the maximum specific sulfatase activity was already attained at lower SUMF1 e
62 The best non-steroidal inhibitor of steroid sulfatase activity was n-lauroyl tryamine phosphate with
64 The poorest non-steroidal based inhibitor of sulfatase activity was tetrahydronaphthyl phosphate with
65 ide association analysis of the variation in sulfatase activity we identified a candidate gene encodi
67 f the requirements for inhibition of estrone sulfatase activity, a number of novel analogues of estro
68 vious observation that AP has a low level of sulfatase activity, further establishing the functional
75 chemical characterization of these potential sulfatases allowed the identification of GAG-specific su
77 double mutation, or by overexpression of 6-O sulfatase, an extracellular enzyme which removes 6-O sul
79 hia coli of the Flavobacterium heparinum 2-O-sulfatase and 6-O-sulfatase enzymes that cleave O-sulfat
80 s of the aromatase inhibitor YM511 inhibited sulfatase and aromatase in JEG-3 cells with respective I
81 of the sulfamate derivatives against steroid sulfatase and carbonic anhydrase II (hCAII) was also obs
83 GALNS, also known as N-acetylgalactosamine-6-sulfatase and GalN6S; E.C. 3.1.6.4) is deficient in pati
84 racterization of 54 glycoside hydrolases, 11 sulfatases and 1 polysaccharide lyase from A. muciniphil
85 ucoidanases, including glycoside hydrolases, sulfatases and carbohydrate esterases, which are primari
86 ases as well as with activators of anaerobic sulfatases and quinohemoprotein amine dehydrogenases.
87 rylsulfatase B (ASB; N-acetylgalactosamine 4-sulfatase) and the subsequent accumulation of the glycos
88 dherin, cyclooxygenase-2, aromatase, steroid sulfatase), and "proliferation factor" (cytokeratin 5, c
90 the enzymes alpha-l-iduronidase, iduronate-2-sulfatase, and N-acetylgalactosamine-4-sulfatase that ar
92 ties for the F. heparinum 2-O-sulfatase, 6-O-sulfatase, and unsaturated glucuronyl hydrolase, we are
93 ontrast, our pruned enzymes were ineffective sulfatases, and this limited promiscuity may have provid
94 d a transient increase in plasma iduronate-2-sulfatase approaching normal levels and one MPS I subjec
95 omeostasis, and that basal levels of steroid sulfatase are sufficient to accommodate acute insults to
97 ctively, these data reveal that carbohydrate sulfatases are highly selective for the glycan component
102 Arylsulfatase B (N-acetylgalactosamine-4-sulfatase; ARSB) removes 4-sulfate groups from chondroit
103 acterized by loss of function of the steroid sulfatase arylsulfatase C (STS), to develop a model of c
104 e sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfat
106 vide a framework that enables the use of 6-O-sulfatase as a tool for HSGAG structure-activity studies
107 modification of expression of the lysosomal sulfatases ASB and GALNS regulates the content of CSs.
111 r the posttranslational activation of type I sulfatases by oxidation of an active-site cysteine to C(
117 SUMF1, a crucial enzyme in the activation of sulfatases, causes a severe chondrodysplasia by augmenti
118 rmed a cluster within a coleopteran-specific sulfatase clade distant from the previously identified G
119 cal posttranslational modification of type I sulfatases, converting cysteine within the motif CxPxR t
121 achromatic leukodystrophy (MLD) and multiple sulfatase deficiency (MSD) displayed a clear deficit in
122 astrocytes to neurodegeneration in multiple sulfatase deficiency (MSD), a severe lysosomal storage d
127 everely disrupted by sulfatase; in addition, sulfatase dramatically inhibited chordomesodermal cell e
128 use of beta-glucuronidase (EC 3.2.1.31) and sulfatase (EC 3.1.6.1) digestion and liquid chromatograp
129 ylsulfatase B (ARSB; N-acetylgalactosamine 4-sulfatase), either innate or acquired, helps to explain
130 th STS protein expression as well as steroid sulfatase enzymatic activity in proportion to the number
134 ational evidence that R/PMH is the first non-sulfatase enzyme shown to use a formylglycine as the cat
135 he use of mixtures of beta-glucuronidase and sulfatase enzymes from different sources was investigate
137 avobacterium heparinum 2-O-sulfatase and 6-O-sulfatase enzymes that cleave O-sulfate groups from spec
141 ities of beta-glucocerebrosidase and steroid sulfatase, enzymes previously linked to barrier maturati
143 oliferator-activated receptor-gamma, steroid sulfatase, estrogen sulfonotransferase, and cytochrome P
145 ively, these data suggest that WT1-dependent sulfatase expression plays a critical role in maintainin
147 FGly is the key catalytic residue of the sulfatase family, comprising 17 nonredundant enzymes in
148 equence homology to other members of a large sulfatase family, especially within its amino terminus,
150 led that mycobacterial strains have distinct sulfatase fingerprints that can be used to judge both th
151 tissue samples with beta-d-glucuronidase and sulfatase, followed by extraction with ethyl acetate and
154 tensive structure-function analysis of a 6-O-sulfatase from the Gram-negative bacterium Flavobacteriu
155 wise report the molecular cloning of the 2-O-sulfatase from the same bacterium and its recombinant ex
156 , we use structural biology to determine how sulfatases from the human gut microbiota recognize sulfa
160 eficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), a lysosomal enzyme required for the s
161 eficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS), leading to accumulation of keratan su
163 The human lysosomal enzyme galactosamine-6-sulfatase (GALNS, also known as N-acetylgalactosamine-6-
164 ica, Europe, and East Asia, whereas Shinella sulfatase gene signatures were first detected in 2020.
167 ed on our previous study, we investigated 10 sulfatase genes induced in the presence of host glycans.
171 whether brief incubation of the plasma with sulfatases/glucuronidases results in complete deconjugat
172 tified 2 autoantigens, N-acetylglucosamine-6-sulfatase (GNS) and filamin A (FLNA), as targets of T an
173 protein extracts revealed that glucosinolate sulfatase (GSS) activity is associated with the gut memb
175 order structures in idursulfase (iduronate-2-sulfatase, I2S) has been accomplished through the use of
176 tide sequence with that of human iduronate 2-sulfatase (IDS) achieved higher transgene expression.
177 mass spectrometry based assay of iduronate-2-sulfatase (IdS) activity for the neonatal detection of m
179 TfR-targeted platforms fused to iduronate 2-sulfatase (IDS), a lysosomal enzyme deficient in mucopol
186 rulation movements are severely disrupted by sulfatase; in addition, sulfatase dramatically inhibited
187 s proposed end-products of sulfamate-induced sulfatase inactivation highlights that an imine N-sulfat
188 with established k(cat) values of bacterial sulfatases indicates that these enzymes produce rate enh
189 the therapeutic potential of dual aromatase-sulfatase inhibition in hormone-dependent breast cancer
190 brain cholinergic function and that steroid sulfatase inhibition may become an important tool for en
192 s studies have demonstrated that the steroid sulfatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyra
193 Administration of the non-steroidal steroid sulfatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyra
194 t of these animals for 24 h with the steroid sulfatase inhibitor COUMATE at a dose (10 mg/kg, p.o.) s
195 e escape latency suggesting that the steroid sulfatase inhibitor did not alter motivation or locomoti
196 innovative dual-targeting aromatase-steroid sulfatase inhibitors (DASIs) and as multitargeting agent
197 pendent cancer, novel dual aromatase-steroid sulfatase inhibitors (DASIs) containing a sulfamate grou
199 n the structural diversity of dual aromatase-sulfatase inhibitors (DASIs), we introduced the steroid
203 t that the chronic administration of steroid sulfatase inhibitors enhance learning and spatial memory
204 upport the concept that nonsteroidal estrone sulfatase inhibitors may be useful as therapeutic agents
205 suggest that the arylsulfamate based steroid sulfatase inhibitors such as COUMATE interfere with the
206 (1) has been studied as a model for steroid sulfatase inhibitors such as Coumate, 667 Coumate, and E
207 have been developed that are potent estrone sulfatase inhibitors, most notably estrone-3-O-sulfamate
211 LSD caused by a deficiency in sulfamidase, a sulfatase involved in the stepwise degradation of glycos
212 s were similar to those of several lysosomal sulfatases involved in degradation of sulfated glycosami
213 al and biochemical studies indicate that 6-O-sulfatase is a predominantly exolytic enzyme that specif
214 Hydrolysis of estrone 3-sulfate by steroid sulfatase is an important additional source of tumor est
215 ype of anteroposterior reduction elicited by sulfatase is distinctly different from commonly generate
217 ylglycine in the catalytic site of mammalian sulfatases is deficient in the rare but devastating diso
220 enzymes beta-glucocerebrosidase and steroid sulfatase, markers of barrier maturation, were reduced i
222 re we present the structures of an anaerobic sulfatase maturating enzyme (anSME), both with and witho
223 tilosin, pyrroloquinoline quinone, anaerobic sulfatase maturating enzyme, and mycofactocin), all of w
224 ture of a SPASM-containing enzyme, anaerobic sulfatase-maturating enzyme (anSME), revealed unexpected
226 produced in CHO cell lines: native GALNS and sulfatase-modifier-factor 1 (SUMF1) modified GALNS.
228 atases that are activated by another enzyme, Sulfatase-Modifying Factor 1 (SUMF1), whose inactivation
229 st & Microbe, Hickey et al. (2015) show that sulfatases of Bacteroides thetaiotaomicron are required
231 on of existing kinetic data reveals that the sulfatase PaAstA catalyzes the hydrolysis of sulfamate e
232 the functional interrelationships among the sulfatases, phosphatases, and phosphodiesterases within
234 At the protein level, the flavobacterial 2-O-sulfatase possesses considerable sequence homology to ot
235 esulfation of mucin by pure sulfatase or the sulfatase-producing commensal Bacteroides thetaiotaomicr
236 marked sequence homology with epitopes from sulfatase proteins of the Prevotella sp. and Parabactero
237 d Sulf-2, which are extracellular neutral-pH sulfatases, provide a novel post-synthetic mechanism for
238 1) of the developmentally regulated putative sulfatases QSulf-1 and RSulfFP1 as well as a cDNA encodi
239 at the levels of r2/3 and r7 expressing the sulfatase QSulf1 in quail, or the orthologue CSulf1 in c
241 ent classes of enzymes (amylase, lipase, and sulfatase), relying on two distinct mechanisms for coupl
242 Inhibition of S1P1 tyrosine sulfation or sulfatase removal of S1P1 sulfate in mouse CD4 T cells s
244 G (ARSG) is the long-sought glucosamine-3-O-sulfatase required to complete the degradation of hepara
245 Bmx nonreceptor tyrosine kinase and steroid sulfatase, respectively) partially regulate the elevated
246 , betaine aldehyde dehydrogenase and choline sulfatase, respectively, are involved in choline metabol
248 ble to bind both Hep and HS, and periplasmic sulfatases reveal the major specificity determinants for
249 They further suggest that the amount of sulfatase secreted by mucin-foraging bacteria such as B.
250 s allowed the identification of GAG-specific sulfatases selective for the type of saccharide residue
251 ison of the structure of GALNS to paralogous sulfatases shows a wide variety of active-site geometrie
252 fied bioinformatically through its conserved sulfatase signature sequence directing posttranslational
255 S232-homologous repeats flanking the steroid sulfatase ( STS ) gene results in STS deletion, which is
256 approach for the dual inhibition of steroid sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase
257 lecular candidate for this effect is Steroid sulfatase (Sts) as this is located in the pseudoautosoma
259 sized and evaluated as inhibitors of estrone sulfatase (STS) in comparison to a lead inhibitor, estro
261 A is exemplified in the discovery of steroid sulfatase (STS) inhibiting lanostane triterpenes (LTTs)
262 gration was blocked by aromatase and steroid sulfatase (STS) inhibitors confirming intracrine synthes
263 nhibitors (DASIs), we introduced the steroid sulfatase (STS) inhibitory pharmacophore to letrozole.
266 diol-3,17-O,O-bis-sulfamates inhibit steroid sulfatase (STS), carbonic anhydrase (CA), and, when subs
270 IRI was prevented by pretreatment with aryl sulfatase, suggesting the presence of a critical sulfo e
271 in 2), JAG1 (jagged 1), SULF2 (extracellular sulfatase Sulf-2), and TIGAR (TP53-inducible glycolysis
272 in 2), JAG1 (jagged 1), SULF2 (extracellular sulfatase Sulf-2), and TIGAR (TP53-inducible glycolysis
275 philic domain (HD) of the human cell-surface sulfatase Sulf1 against its physiological glycosaminogly
278 tudy, we demonstrated that the extracellular sulfatase, SULF2, an enzyme that regulates multiple HSPG
279 umor suppressor, but the role of the related sulfatase, sulfatase 2 (SULF2), in liver carcinogenesis
281 e evolved more sophisticated and diverse GAG sulfatases than anticipated and establishes how B. theta
282 ate-2-sulfatase, and N-acetylgalactosamine-4-sulfatase that are used for newborn screening of mucopol
283 G (ARSG) is a recently identified lysosomal sulfatase that was shown to be responsible for the degra
284 Sulf-1 and Sulf-2 are novel extracellular sulfatases that act on internal glucosamine 6-O-sulfate
285 ry step for their degradation, is exerted by sulfatases that are activated by another enzyme, Sulfata
290 he substrate-product relationship of the 2-O-sulfatase to the Delta4,5-glycuronidase and the analytic
298 n with glucuronidase and mixed glucuronidase/sulfatase were used to validate the accuracy of the quan
299 ed Carbohydrate-Active enzymes (CAZymes) and sulfatases were tested, individually or combined, accord
300 ts glucosylceramide to ceramide, and steroid sulfatase, which desulfates cholesterol sulfate, also in
301 lfamates is ineffective against carbohydrate sulfatases, yet can inhibit human gut microbiota (HGM) s